EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

APOE ε4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis

Yuya Hatano, Asa Nakahara, Mari Tada, Akiyoshi Kakita, Osamu Onodera, Tomohiko Ishihara

Acta Neuropathologica · 15.05.2026 · 151 (1)

DOI: 10.1007/s00401-026-03029-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 15.05.2026. Verfasst von Yuya Hatano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Apolipoprotein E4, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS J-PEAKS Program, the AMED-SICORP program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder, most sporadic cases exhibiting TAR DNA-binding protein 43 (TDP-43) pathology. The anatomical distribution of TDP-43 pathology varies among patients; however, factors contributing to this heterogeneity remain unclear. Apolipoprotein E ( APOE ) ε4 is known to influence the spread of pathological protein in several neurodegenerative diseases, raising the possibility that it also modulates the pathological distribution of TDP-43 inclusions in ALS. We investigated this hypothesis in a cohort of 145 autopsy-confirmed sporadic ALS cases. ALS-associated TDP-43 pathology was classified into two subtypes: type 1 – largely restricted to motor regions – and type 2 – characterized by widespread cortical involvement. APOE genotypes and rare variants in known ALS-associated genes were determined by exome sequencing. Amyloid-β and tau pathologies were assessed neuropathologically using established staging systems. Structural equation modeling (SEM) was applied to disentangle direct and indirect relationships among APOE ε4, temporal clinical parameters, Alzheimer’s disease-related pathologies, and ALS TDP-43 subtype. Furthermore, we also performed an unbiased evaluation using random forest model. APOE ε4 carriers showed a significantly higher proportion of type 2 pathology than non-carriers. Bayesian SEM demonstrated that APOE ε4 was directly associated with the type 2, widespread TDP-43 subtype, independent of amyloid-β and tau pathology, while also reproducing the canonical cascade linking APOE ε4 to amyloid-β and tau. Rare variants in ALS-associated genes showed no clear effect on TDP-43 subtype. These findings indicate that APOE ε4 modifies the anatomical distribution of TDP-43 pathology in sporadic ALS through mechanisms independent of classical Alzheimer’s disease pathology. Incorporation of APOE genotype into ALS stratification may be informative for biologically grounded subtype-specific therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisDNA-Binding ProteinsApolipoprotein E4BrainHumansFemaleMaleAgedMiddle AgedAged, 80 and overGenotype

Stichwörter der Autor:innen

APOEAmyloid-βAmyotrophic lateral sclerosisStructural equation modelingTDP-43 pathologyTau

Substanzen

DNA-Binding ProteinsTARDBP protein, humanApolipoprotein E4

Autor:innen und Institutionen

  • Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Department of Neurology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Minamiuonuma, Japan.
  • Department of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Center for Human Brain Resource Initiative (ChBRI), Niigata University, Niigata, Japan.
  • Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan. ishihara@bri.niigata-u.ac.jp.
  • Advanced Treatment of Neurological Diseases Branch, Endowed Research Branch, Brain Research Institute, Niigata University, 1-757 Asahimachi-Dori, Chuo-Ku, Niigata, 951-8585, Japan. ishihara@bri.niigata-u.ac.jp.

Förderung

  • Japan Society for the Promotion of Science
  • JSPS J-PEAKS Program
  • the AMED-SICORP program
  • the Ministry of Health, Labour and Welfare (Research on Rare and Intractable Diseases Program)
  • AMED MoonShot Program
  • Tsubaki Memorial Foundation

Zitieren

APA

Hatano, Y., Nakahara, A., Tada, M., Kakita, A., Onodera, O., & Ishihara, T. (2026). APOE ε4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis. Acta Neuropathologica, 151(1). https://doi.org/10.1007/s00401-026-03029-y

Vancouver

Hatano Y, Nakahara A, Tada M, Kakita A, Onodera O, Ishihara T. APOE ε4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis. Acta Neuropathologica. 2026;151(1). doi:10.1007/s00401-026-03029-y

BibTeX
@article{Hatano2026,
  author = {Hatano, Yuya and Nakahara, Asa and Tada, Mari and Kakita, Akiyoshi and Onodera, Osamu and Ishihara, Tomohiko},
  title = {APOE ε4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis},
  journal = {Acta Neuropathologica},
  year = {2026},
  volume = {151},
  number = {1},
  doi = {10.1007/s00401-026-03029-y}
}
Kostenlos starten →